MX2017014417A - Vacunas contra el dengue. - Google Patents

Vacunas contra el dengue.

Info

Publication number
MX2017014417A
MX2017014417A MX2017014417A MX2017014417A MX2017014417A MX 2017014417 A MX2017014417 A MX 2017014417A MX 2017014417 A MX2017014417 A MX 2017014417A MX 2017014417 A MX2017014417 A MX 2017014417A MX 2017014417 A MX2017014417 A MX 2017014417A
Authority
MX
Mexico
Prior art keywords
denv
conserved
dengue virus
sequences
virus serotypes
Prior art date
Application number
MX2017014417A
Other languages
English (en)
Inventor
Blight Joshua
Reyes-Sandoval Arturo
Lopez-Camacho Cesar
Original Assignee
Univ Oxford Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oxford Innovation Ltd filed Critical Univ Oxford Innovation Ltd
Publication of MX2017014417A publication Critical patent/MX2017014417A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5258Virus-like particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10023Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La invención se refiere a una proteína que comprende una pluralidad de secuencias de péptido conservadas o variantes de las mismas, en donde al menos una de las secuencias conservadas se conserva a través de todos los cuatro serotipos del virus del dengue DEN-1, DEN-2, DEN- 3 y DEN-4, y en donde las secuencias conservadas comprenden al menos parte de una secuencia de una o más proteínas no-estructurales de los serotipos del virus del dengue. La invención además se refiere a péptidos asociados, composiciones, ácidos nucleicos, vectores virales, partículas similares al virus, uso, kits de vacunación principal y de refuerzo, agentes y métodos.
MX2017014417A 2015-05-12 2016-05-11 Vacunas contra el dengue. MX2017014417A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1508099.7A GB201508099D0 (en) 2015-05-12 2015-05-12 Dengue vaccines
PCT/GB2016/051358 WO2016181147A1 (en) 2015-05-12 2016-05-11 Dengue vaccines

Publications (1)

Publication Number Publication Date
MX2017014417A true MX2017014417A (es) 2018-06-20

Family

ID=53489497

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017014417A MX2017014417A (es) 2015-05-12 2016-05-11 Vacunas contra el dengue.

Country Status (6)

Country Link
US (1) US10350285B2 (es)
EP (1) EP3294331A1 (es)
BR (1) BR112017024283A8 (es)
GB (1) GB201508099D0 (es)
MX (1) MX2017014417A (es)
WO (1) WO2016181147A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11806393B2 (en) * 2017-02-10 2023-11-07 La Jolla Institute For Allergy And Immunology Flavivirus peptide sequences, epitopes, and methods and uses thereof
BR112020009157A2 (pt) * 2017-11-09 2020-10-27 Institut Pasteur poliepítopo quimérico, polinucleotídeo, vetor, célula hospedeira e composição imunogênica
WO2022169665A1 (en) * 2021-02-05 2022-08-11 Unm Rainforest Innovations Bacteriophage virus-like particle vaccines against flavivirus non-structural protein 1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002356690B2 (en) * 2001-12-04 2008-07-24 Bavarian Nordic A/S Flavivirus NS1 subunit vaccine
WO2011163628A2 (en) 2010-06-24 2011-12-29 La Jolla Institute For Allergy And Immunology Dengue virus (dv) polypeptide sequences, t cell epitopes and methods and uses thereof

Also Published As

Publication number Publication date
BR112017024283A2 (pt) 2018-07-24
US10350285B2 (en) 2019-07-16
GB201508099D0 (en) 2015-06-24
WO2016181147A1 (en) 2016-11-17
BR112017024283A8 (pt) 2022-12-27
US20180193446A1 (en) 2018-07-12
EP3294331A1 (en) 2018-03-21

Similar Documents

Publication Publication Date Title
WO2017058892A3 (en) Methods and compositions for antibody-evading virus vectors
CO2020004738A2 (es) Variantes de cápsides de virus adenoasociados y métodos de uso de estas
WO2017066764A3 (en) Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses
MX2017012097A (es) Variantes de virus adenoasociado y métodos de uso de estas.
MX2017002791A (es) Vacuna contra filovirus de virus vaccinia ankara modificado (mva) recombinante.
EA201891712A3 (ru) Молекулы нуклеиновых кислот гриппа и вакцины, изготовленные из них
HRP20211601T1 (hr) Rekombinantni proteini bez fenilalanina (phe) za liječenje fenilketonurije
MX2013008836A (es) Moleculas de acido nucleico que codifican novedosos antigenos de herpes, vacunas que las comprenden y metodos para su uso.
CL2012000447A1 (es) Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica.
MX343830B (es) Molecula de acido nucleico que codifica la proteina nuclear del virus de la hepatitis b y vacuna que comprende la misma.
AR071910A1 (es) Vacuna combinada para el papiloma humano y el sarampion. vector. huesped.
EA202090759A3 (ru) Коровый белок вируса гепатита в и поверхностный антигенный белок и содержащая их вакцина
CA3009928A1 (en) Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine
PH12016502554A1 (en) A dengue virus chimeric polyepitope composed of fragments of non structural proteins and its use in an immunogenic composition against dengue virus infection
WO2016116905A9 (en) Cmv antigens and uses thereof
MX2017014417A (es) Vacunas contra el dengue.
AR108014A1 (es) Vacuna universal para enfermedades virales y método de vacunación
MX363149B (es) Vacunas de nucleoproteina de la influenza.
EA201990719A1 (ru) Новые промоторы
PH12017501100B1 (en) Recombinant swinepox virus and vaccines
MX2020007777A (es) Vacunas contra virus de la gripe y usos de las mismas.
AR095425A1 (es) Vacuna, uso y procedimiento para prevenir una infección por picornavirus
EA201890187A1 (ru) Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита
MX2020006476A (es) Vacuna contra el virus de lassa.
EA201890274A1 (ru) Векторная система из аденовируса 9 птиц (fadv-9) и связанные способы